BrightPath Biotherapeutics Co (TSE:4594) Cash from Discontinued Operating Activities : 円0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is BrightPath Biotherapeutics Co Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

BrightPath Biotherapeutics Co's Cash from Discontinued Operating Activities for the three months ended in Dec. 2023 was 円0.00 Mil. It means BrightPath Biotherapeutics Co received 円0.00 Mil from discontinued investing activities. BrightPath Biotherapeutics Co's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 was 円0.00 Mil.

BrightPath Biotherapeutics Co Cash from Discontinued Operating Activities Historical Data

The historical data trend for BrightPath Biotherapeutics Co's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrightPath Biotherapeutics Co Cash from Discontinued Operating Activities Chart

BrightPath Biotherapeutics Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Cash from Discontinued Operating Activities

Get a 7-Day Free Trial

BrightPath Biotherapeutics Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash from Discontinued Operating Activities	Get a 7-Day Free Trial															-	-	-	-	-

BrightPath Biotherapeutics Co Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

BrightPath Biotherapeutics Co Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of BrightPath Biotherapeutics Co's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

BrightPath Biotherapeutics Co (TSE:4594) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BrightPath Biotherapeutics Co Ltd (TSE:4594) » Definitions » Cash from Discontinued Operating Activities

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-2-4 Kojimachi, Kojimachi Central Building 7th Floor, Chiyoda-ku, Tokyo, JPN

Website

https://www.brightpathbio.com

BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.

BrightPath Biotherapeutics Co (TSE:4594) Headlines

No Headlines